Intensity Therapeutics, Inc.INTSNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank42
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P42
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -1.04% |
| Q2 2025 | 20.30% |
| Q1 2025 | -5.96% |
| Q4 2024 | 10.28% |
| Q3 2024 | 29.57% |
| Q2 2024 | -6.87% |
| Q1 2024 | -41.47% |
| Q4 2023 | -34.59% |
| Q3 2023 | -103.90% |
| Q2 2023 | 2.59% |
| Q1 2023 | 19.39% |
| Q4 2022 | 11.99% |
| Q3 2022 | 8.39% |
| Q2 2022 | 18.87% |
| Q1 2022 | 1.32% |
| Q4 2021 | -12.74% |
| Q3 2021 | -8.81% |
| Q2 2021 | -30.90% |
| Q1 2021 | 9.44% |
| Q4 2020 | 0.00% |